As indicated in my response to the previous post the link provided was to a patent application that has been abandoned in the US, so it obviously hasn't been and won't be providing any protection at all.
I don't know how this stuff works vis-a-vis patent protection periods for a drug that has yet to be approved, but I get the impression that I still have years to figure that out: "first must come the tox package completion and INDA submission which are all predicated by successful scale up."
"plus another 3 to 7 years of market exclusivity depending on the FDA qualifying approval" What would the basis be for a period of market exclusivity?